Trial Profile

Pantoprazole 20/40 mg in Reflux-Associated Complaints With Focus on Gastrointestinal Symptoms.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pantoprazole (Primary)
Indications Gastro-oesophageal reflux
Focus Therapeutic Use
Acronyms PARADE
Sponsors Takeda Pharmaceuticals International GmbH

Most Recent Events

07 May 2012 Company (Takeda Pharmaceuticals International GmbH) added in the association field as reported by ClinicalTrials.gov.
07 May 2012 Additional lead trial centre (Takeda Pharmaceuticals International GmbH) identified as reported by ClinicalTrials.gov.
07 May 2012 Company (Takeda Global Research and Development Center) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com